Australian women suffering life-long complications from transvaginal surgical mesh have won a landmark case against pharmaceutical giant Johnson & Johnson and two of its affiliated companies.
Federal Court Justice Anna Katzmann found in favour of the group of 1200 women in the case against Johnson & Johnson on Thursday.
Complications included chronic inflammatory reaction, erosion of mesh into surrounding organs, infection, chronic pain, pain with sex, incontinence, damage to surrounding tissues, haemorrhage, leg weakness, further surgery and psychological injury.
The mesh products were used to treat stress urinary incontinence or uterus prolapse after childbirth in Australia and New Zealand.
* US Food and Drug Administration halts pelvic organ mesh sales
* Auckland woman dead after two years of pain from surgical mesh
* Questions raised over whether Kiwi surgeons have enough experience and skill for transvaginal mesh implants
Katzmann said Johnson & Johnson and mesh manufactures Ethicon Sarl and Ethicon Inc engaged in misleading conduct, and each was negligent as the risks for the devices were “known, and not insignificant”.